Adenosine kinase: exploitation for therapeutic gain

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Adenosine kinase (ADK) is a key enzyme in adenosine metabolism, regulating its homeostatic and metabolic functions.
• Adenosine signaling influences essential pathways, including energy metabolism and epigenetics, via adenosine receptors.
• ADK dysfunction is implicated in various pathologies, such as diabetes, epilepsy, and cancer.

Purpose of the Study:

• To provide a comprehensive review of adenosine kinase (ADK).
• To explore the genetics, biochemistry, and pharmacology of ADK.
• To focus on ADK's role in pathologies and therapeutic interventions.

Main Methods:

• Literature review of ADK genetics, biochemistry, and pharmacology.
• Analysis of ADK's role in disease pathogenesis.
• Evaluation of current and emerging therapeutic strategies targeting ADK.

Main Results:

• ADK is an upstream regulator of complex homeostatic and metabolic networks.
• ADK dysfunction is linked to diabetes, epilepsy, and cancer.
• Novel findings suggest ADK's involvement in a broader spectrum of diseases.

Conclusions:

• ADK is a promising therapeutic target for reconstructing network homeostasis.
• Targeting ADK presents innovative opportunities for treating diverse pathologies.
• Challenges in translating ADK-based therapies to clinical practice require critical discussion.